QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.24%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.24%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.24%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.24%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
OTCMKTS:INVVY

Indivior - INVVY Stock Forecast, Price & News

$20.14
-0.91 (-4.32%)
(As of 11/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$20.14
$20.14
50-Day Range
$14.85
$23.31
52-Week Range
$14.22
$23.31
Volume
315 shs
Average Volume
3,429 shs
Market Capitalization
$2.76 billion
P/E Ratio
19.18
Dividend Yield
N/A
Price Target
N/A
INVVY stock logo

About Indivior (OTCMKTS:INVVY) Stock

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Receive INVVY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter.

INVVY Stock News Headlines

Two factors to watch at Indivior - Yahoo Finance UK
See More Headlines
Receive INVVY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter.

INVVY Company Calendar

Today
11/30/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:INVVY
Previous Symbol
NASDAQ:INVVY
CIK
N/A
Employees
800
Year Founded
N/A

Profitability

Net Income
$205 million
Pretax Margin
21.15%

Debt

Sales & Book Value

Annual Sales
$791 million
Cash Flow
$1.02 per share
Book Value
$1.45 per share

Miscellaneous

Free Float
N/A
Market Cap
$2.76 billion
Optionable
Not Optionable
Beta
0.31

Key Executives

  • Mr. Mark Crossley
    CEO & Exec. Director
  • Mr. Ryan Preblick
    CFO & Exec. Director
  • Dr. Christian Heidbreder
    Chief Scientific Officer
  • Mr. Jason Thompson
    VP of Investor Relations
  • Ms. Cynthia Cetani
    Chief Integrity & Compliance Officer
  • Mr. Jeffrey W. Burris (Age 50)
    Chief Legal Officer
  • Mr. Jon Fogle
    Chief HR Officer
  • Mr. Richard Simkin
    Chief Commercial & Strategy Officer
  • Mr. Hillel West
    Chief Manufacturing & Supply Officer
  • Ms. Nina DeLorenzo
    Chief Global Impact Officer













INVVY Stock - Frequently Asked Questions

Should I buy or sell Indivior stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" INVVY shares.
View INVVY analyst ratings
or view top-rated stocks.

How have INVVY shares performed in 2022?

Indivior's stock was trading at $17.19 on January 1st, 2022. Since then, INVVY stock has increased by 17.2% and is now trading at $20.14.
View the best growth stocks for 2022 here
.

Are investors shorting Indivior?

Indivior saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 14,700 shares, a drop of 22.6% from the October 15th total of 19,000 shares. Based on an average daily trading volume, of 2,400 shares, the short-interest ratio is presently 6.1 days.
View Indivior's Short Interest
.

What guidance has Indivior issued on next quarter's earnings?

Indivior updated its FY 2022 earnings guidance on Thursday, November, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $890.00 million-$915.00 million.

What is Indivior's stock symbol?

Indivior trades on the OTCMKTS under the ticker symbol "INVVY."

How do I buy shares of Indivior?

Shares of INVVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Indivior's stock price today?

One share of INVVY stock can currently be purchased for approximately $20.14.

How much money does Indivior make?

Indivior (OTCMKTS:INVVY) has a market capitalization of $2.76 billion and generates $791 million in revenue each year. The company earns $205 million in net income (profit) each year or $1.05 on an earnings per share basis.

How many employees does Indivior have?

The company employs 800 workers across the globe.

How can I contact Indivior?

Indivior's mailing address is 10710 Midlothian Turnpike, North Chesterfield VA, 23235. The official website for the company is www.indivior.com. The company can be reached via phone at 804-379-1090, via email at investorrelations@indivior.com, or via fax at 804-379-1215.

This page (OTCMKTS:INVVY) was last updated on 11/30/2022 by MarketBeat.com Staff